Financial Advocates Investment Management Silo Pharma, Inc. Transaction History

Financial Advocates Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$0.96 - $2.3 $37,314 - $89,398	-38,869 Reduced 61.89%	23,938 $23,000
Q4 2023 Feb 08, 2024	BUY	$1.3 - $1.84 $7,150 - $10,120	5,500 Added 9.6%	62,807 $90,000
Q3 2023 Oct 27, 2023	SELL	$1.67 - $2.3 $334 - $459	-200 Reduced 0.35%	57,307 $95,000
Q2 2023 Aug 07, 2023	BUY	$1.96 - $2.4 $25,480 - $31,200	13,000 Added 29.21%	57,507 $117,000
Q1 2023 May 11, 2023	BUY	$1.85 - $3.07 $54,575 - $90,565	29,500 Added 196.57%	44,507 $93,000
Q4 2022 Feb 14, 2023	BUY	$2.61 - $5.94 $39,168 - $89,141	15,007 New	15,007 $50,000

338K

Ticker SILO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,137,910
Market Cap $3.17M
Description
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.